Related references
Note: Only part of the references are listed.Small interfering RNA targeting HIF-1α reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro
Adrian Staab et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2011)
HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression
Jacqueline Kessler et al.
BMC CANCER (2010)
Increased chemoresistance induced by inhibition of HIF-prolyl-hydroxylase domain enzymes
Nils Broekers et al.
CANCER SCIENCE (2010)
Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD
Wanja M. Bernhardt et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Radiosensitization and Stromal Imaging Response Correlates for the HIF-1 Inhibitor PX-478 Given with or without Chemotherapy in Pancreatic Cancer
David L. Schwartz et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Relationships between Cycling Hypoxia, HIF-1, Angiogenesis and Oxidative Stress
Mark W. Dewhirst
RADIATION RESEARCH (2009)
Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Mark W. Dewhirst et al.
NATURE REVIEWS CANCER (2008)
HIF-2α promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity
John D. Gordan et al.
CANCER CELL (2007)
Hypoxia-regulated p53 and its effect on radiosensitivity in cancer cells
Li Zhang et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2007)
Cell-specific regulation of hypoxia-inducible factor (HIF)-1α and HIF-2α stabilization and transactivation in a graded oxygen environment
Cameron P. Bracken et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
HIF-2α regulates Oct-4:: effects of hypoxia on stem cell function, embryonic development, and tumor growth
KL Covello et al.
GENES & DEVELOPMENT (2006)
Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial
J Overgaard et al.
LANCET ONCOLOGY (2005)
Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia
P Vaupel et al.
ONKOLOGIE (2005)
Cell type-specific association of hypoxia-inducible factor-1α (HIF-1α) protein accumulation and radiobiologic tumor hypoxia
D Vordermark et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Thermochemoradiotherapy improves oxygenation in locally advanced breast cancer
EL Jones et al.
CLINICAL CANCER RESEARCH (2004)
Effect of radiation and ibuprofen on normoxic renal carcinoma cells overexpressing hypoxia-inducible factors by loss of von Hippel-Lindau tumor suppressor gene function
ST Palayoor et al.
CLINICAL CANCER RESEARCH (2004)
Tumor hypoxia: Causative factors, compensatory mechanisms, and cellular response
P Vaupel et al.
ONCOLOGIST (2004)
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules
BJ Moeller et al.
CANCER CELL (2004)
Differential roles of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in hypoxic gene regulation
CJ Hu et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Regulation of gene expression by oxygen:: NF-κB and HIF-1, two extremes
C Michiels et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Association of hypoxia-inducible factors 1α and 2α with activated angiogenic pathways and prognosis in patients with endometrial carcinoma
E Sivridis et al.
CANCER (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies
JM Brown
MOLECULAR MEDICINE TODAY (2000)
Share Paper
